Literature DB >> 14971736

Characterisation of ACTH related peptides in ectopic Cushing's syndrome.

Robert L Oliver1, Julian R E Davis, Anne White.   

Abstract

Adrenocorticotrophin (ACTH) is derived by cleavage from the precursor, pro-opiomelanocortin (POMC), and depending on the degree of processing by the tissue or tumor, there is the potential for a number of ACTH-related peptides to be secreted from POMC expressing cells. Previous chromatographic approaches have indicated the presence of high molecular weight forms of ACTH in the human peripheral circulation. However a quantitative assessment of the degree of processing requires two-site immunoradiometric assays which distinguish ACTH precursors and ACTH. Using this approach, we have previously identified the precursors of ACTH (POMC and proACTH) in the circulation of normal subjects in the range 5-40 pmol/l, which suggests that processing in the normal pituitary cell is incomplete. This study aimed to examine the extent of POMC processing by tumors that give rise to Cushing's Syndrome as a means of evaluating its usefulness as a diagnostic marker. In a retrospective analysis of 86 patients with Cushing's Syndrome, 34/35 patients with pituitary tumors had low levels of ACTH precursors (below 100 pmol/l) and the mean ratio of ACTH precursors:ACTH was 5:1 which indicates that these tumors do process POMC to ACTH relatively efficiently. In ectopic Cushing's Syndrome, it is unlikely that the extra-pituitary tumor cells, process POMC as efficiently. Therefore increased prevalence of ACTH precursors in the circulation would be expected and this was substantiated by the large excess of ACTH precursors (139-18,000 pmol/l) in the circulation of the 51 patients with the ectopic ACTH Syndrome. The diagnostic accuracy of the measurement of ACTH precursors was then prospectively compared with a group of 62 patients undergoing the current "gold standard" test of inferior petrosal sinus sampling (IPSS). All those patients with ACTH precursors below a diagnostic cut-off of 100 pmol/l were subsequently shown to have pituitary tumors, whereas levels of >100 pmol/l were seen in the four patients with ectopic tumors. In comparison the IPSS had a specificity of 100% but a sensitivity of 93% and for these false negative results the ACTH precursors proved diagnostically useful. Therefore measurement of ACTH precursors offers a simple non-invasive diagnostic test for the differential diagnosis of Cushing's Syndrome which compares favourably with IPSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14971736     DOI: 10.1023/b:pitu.0000011172.26649.df

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  32 in total

1.  Cushing's syndrome in a 16 year old girl due to ectopic ACTH precursor production from a pancreatic tumour.

Authors:  J Hinnie; C E Gray; A M McNicol; R Carter; J A Thomson; A White; I W Campbell; A McBain
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

2.  In vitro release and biosynthesis of tumor ACTH in ectopic ACTH producing tumors.

Authors:  Y Hirata; H Yamamoto; S Matsukura; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

Review 3.  ACTH precursors: biological significance and clinical relevance.

Authors:  A White; S Gibson
Journal:  Clin Endocrinol (Oxf)       Date:  1998-03       Impact factor: 3.478

4.  Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques.

Authors:  P Loli; F Vignati; E Grossrubatscher; P Dalino; M Possa; F Zurleni; G Lomuscio; O Rossetti; M Ravini; A Vanzulli; C Bacchetta; C Galli; D Valente
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

5.  ACTH and MSH production by a single cloned mouse pituitary tumor cell line.

Authors:  D N Orth; W E Nicholson; W M Mitchell; D P Island; M Shapiro; R L Byyny
Journal:  Endocrinology       Date:  1973-02       Impact factor: 4.736

Review 6.  Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.

Authors:  L E Pritchard; A V Turnbull; A White
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

7.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

8.  The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.

Authors:  Giuseppe Reimondo; Piero Paccotti; Marco Minetto; Angela Termine; Guido Stura; Mauro Bergui; Alberto Angeli; Massimo Terzolo
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

9.  Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.

Authors:  S Gibson; S R Crosby; M F Stewart; A M Jennings; E McCall; A White
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

10.  ACTH precursors characterize the ectopic ACTH syndrome.

Authors:  P M Stewart; S Gibson; S R Crosby; R Penn; R Holder; D Ferry; N Thatcher; P Phillips; D R London; A White
Journal:  Clin Endocrinol (Oxf)       Date:  1994-02       Impact factor: 3.478

View more
  17 in total

Review 1.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

2.  Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.

Authors:  S T Sharma; L K Nieman
Journal:  Eur J Endocrinol       Date:  2011-12-21       Impact factor: 6.664

Review 3.  Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be.

Authors:  Arno Téblick; Jan Gunst; Greet Van den Berghe
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

4.  Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  Gabrielle Page-Wilson; Pamela U Freda; Thomas P Jacobs; Alexander G Khandji; Jeffrey N Bruce; Sandra T Foo; Kana Meece; Anne White; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

5.  Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Authors:  N A Shah; I A Urusova; A D'Agnolo; S D Colquhoun; B E Rosenbloom; S L Vener; S A Geller; M Younes; J Lechago; A P Heaney
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

6.  Bilateral adrenalectomy for ectopic Cushing's syndrome-discussions on technique and indication.

Authors:  Per Hellman; Fredrik Linder; Joakim Hennings; Ola Hessman; Barbro Eriksson; Håkan Orlefors; Göran Akerström
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

7.  A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1.

Authors:  Gul Bano; Farheen Mir; Nigel Beharry; Philip Wilson; Shirley Hodgson; Stephen Schey
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

Review 8.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02

9.  Low renin hypertension.

Authors:  Manisha Sahay; Rakesh K Sahay
Journal:  Indian J Endocrinol Metab       Date:  2012-09

10.  Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.

Authors:  R Stovold; S L Meredith; J L Bryant; M Babur; K J Williams; E J Dean; C Dive; F H Blackhall; A White
Journal:  Br J Cancer       Date:  2013-03-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.